ClinicalTrials.govrestricted
Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2
ClinicalTrials.gov study NCT05844436. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ShareScore
16/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 8
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 4